MAPT and Parkinson disease: Přikrylová Vranová et al. (2010) found increased CSF tau levels in PD patients with less than 2 years of evolution, and increased CSF tau levels which were higher in patients with PDD than in PD, and in PD than in controls, and similar CSF tau in DLDB than in controls (Vranová et al., 2014).